Biopolymer formulations for drug delivery
Patent Information
- Authority / Receiving Office
- JP · JP
- Patent Type
- Applications
- Current Assignee / Owner
- 11584022 CANADA INC
- Filing Date
- 2023-06-29
- Publication Date
- 2026-07-06
AI Technical Summary
There is a need for new methods of incorporating biopolymers into drug delivery systems (DDS) that are non-toxic, biocompatible, and biodegradable, as conventional biopolymers like cellulose and chitin are insoluble, limiting their use.
A homogeneous suspension of biopolymers, such as chitin and chitosan, is mechanically treated under high shear conditions to form a stable, homogeneous aqueous composition for drug delivery, retaining hydrophilic and hydrophobic molecules, and can be formulated into pastes, creams, lotions, or gels for controlled release.
The biopolymer suspension provides a stable, controlled release of pharmaceutical active ingredients, reducing unwanted interactions and maintaining stability for extended periods, suitable for various administration routes including topical and oral.
Smart Images

Figure 00000000_0000_ABST